Stocks and Investing Stocks and Investing
Wed, December 18, 2019
Tue, December 17, 2019

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $150 on, Dec 17th, 2019


Published on 2024-10-26 19:14:47 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $141 to $150 on, Dec 17th, 2019.

David has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $96 on, Wednesday, September 4th, 2019


These are the ratings of the 4 analyists that currently disagree with David


  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $159 on, Thursday, November 21st, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $145 on, Tuesday, September 3rd, 2019
Contributing Sources